SCHEMBL21714577

SCHEMBL21714577

COc1cc2[nH]c3c(C(F)(F)F)nccc3c2cc1F

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 12/20 0.65
MAOA P21397 4/20 0.41
CCNB2 O95067 2/20 0.41
CDK1 P06493 2/20 0.41
CCNB1 P14635 2/20 0.41
CCNA2 P20248 2/20 0.41
CDK2 P24941 2/20 0.41
CCNA1 P78396 2/20 0.41
CDK5 Q00535 2/20 0.41
CDK5R1 Q15078 2/20 0.41
CCNB3 Q8WWL7 2/20 0.41
ACHE P22303 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
DYRK3 O43781 1/20 0.41
CCNT1 O60563 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADRA2A P08913 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30939885 0.79 DYRK1A (1.00) DYRK1AMAOACCNB2CDK1CCNB1
SCHEMBL16123489 0.79 DYRK1A (1.00) DYRK1AMAOACCNB2CDK1CCNB1
SCHEMBL21714647 0.77 DYRK1A (0.59) DYRK1AMAOACCNB2CDK1CCNB1
SCHEMBL21714296 0.77 DYRK1A (0.55) DYRK1AMAOACCNB2CDK1CCNB1
SCHEMBL21711313 0.76 DYRK1A (0.54) DYRK1AMAOACCNB2CDK1CCNB1
SCHEMBL10615940 0.75 DYRK1A (0.59) DYRK1AMAOACCNB2CDK1CCNB1
SCHEMBL31546615 0.72 DYRK1A (0.39) DYRK1AMAOACCNB2CDK1CCNB1
SCHEMBL6123207 0.71 DYRK1A (0.54) DYRK1AALDH1A1SMN1; SMN2PIM3BCHE
SCHEMBL30940005 0.71 DYRK1A (0.65) DYRK1AMAOACCNB2CDK1CCNB1
SCHEMBL16102671 0.71 DYRK1A (0.65) DYRK1AMAOACCNB2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3837241-B1 FLUORO SS-CARBOLINE COMPOUNDS FOR THE TREATMENT OF BONE HOMEOSTASIS OSSIFI THERAPEUTICS LLC (US) 2026-04-22 EP disclosed
US-20260097041-A1 FLUORO BETA-CARBOLINE COMPOUNDS OSSIFI THERAPEUTICS LLC (US) 2026-04-09 US disclosed
US-12324809-B2 Fluoro beta-carboline compounds OSSIFI THERAPEUTICS LLC (US) 2025-06-10 US disclosed
US-20250025472-A1 FLUORO BETA-CARBOLINE COMPOUNDS OSSIFI THERAPEUTICS LLC 2025-01-23 US disclosed
US-11903949-B2 Fluoro beta-carboline compounds OSSIFI THERAPEUTICS LLC (US) 2024-02-20 US disclosed
CN-113166058-A Fluoro beta-carboline compounds 奥斯特克有限公司 2021-07-23 CN disclosed
US-20200054645-A1 FLUORO BETA-CARBOLINE COMPOUNDS OSSIFI THERAPEUTICS LLC 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250025472-A1 FLUORO BETA-CARBOLINE COMPOUNDS GLS, AFF1, SLC5A1 DYRK1A 3077/4885MAOA 3861/4885CCNB2 1155/4885
US-20260097041-A1 FLUORO BETA-CARBOLINE COMPOUNDS CTNNB1, SLC5A1, SLC5A2 DYRK1A 1466/4885MAOA 3103/4885CCNB2 1709/4885
US-20200054645-A1 FLUORO BETA-CARBOLINE COMPOUNDS GLS, AFF1, SLC5A1 DYRK1A 3077/4885MAOA 3861/4885CCNB2 1155/4885
US-11903949-B2 Fluoro beta-carboline compounds GLS, AFF1, SLC5A1 DYRK1A 3077/4885MAOA 3861/4885CCNB2 1155/4885
US-12324809-B2 Fluoro beta-carboline compounds GLS, AFF1, SLC5A1 DYRK1A 3077/4885MAOA 3861/4885CCNB2 1155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.